To understand the molecular mechanisms by which TLR9 enhances PD-L1 transcription in HCC, we silenced the transcription factors MYC, JUN, IRF1, IRF3, STAT1 and STAT3 by gene inhibition. The gene discussed is STAT3; the disease is hepatocellular carcinoma.